vs
Greenidge Generation Holdings Inc.（GREE）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Greenidge Generation Holdings Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.3倍（$11.5M vs $9.1M），Greenidge Generation Holdings Inc.净利率更高（26.3% vs -60.3%，领先86.6%），Greenidge Generation Holdings Inc.同比增速更快（-22.6% vs -49.9%），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -23.0%）
Greenidge Generation Holdings Inc.是一家总部位于美国的企业，运营一体化加密货币挖矿设施及低碳发电资产，涵盖天然气与可再生能源项目，专注于实现数字资产挖矿业务与能源高效利用的协同，主要服务北美数字资产及能源领域客户。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
GREE vs PLX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5M | $9.1M |
| 净利润 | $3.0M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 14.7% | -51.1% |
| 净利率 | 26.3% | -60.3% |
| 营收同比 | -22.6% | -49.9% |
| 净利润同比 | 177.1% | -184.8% |
| 每股收益（稀释后） | $0.26 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $11.5M | $9.1M | ||
| Q3 25 | $15.2M | $17.9M | ||
| Q2 25 | $12.9M | $15.7M | ||
| Q1 25 | $19.2M | $10.1M | ||
| Q4 24 | $14.8M | $18.2M | ||
| Q3 24 | $12.4M | $18.0M | ||
| Q2 24 | $13.1M | $13.5M | ||
| Q1 24 | $19.3M | — |
| Q4 25 | $3.0M | $-5.5M | ||
| Q3 25 | $12.0M | $2.4M | ||
| Q2 25 | $-4.1M | $164.0K | ||
| Q1 25 | $-5.6M | $-3.6M | ||
| Q4 24 | $-3.9M | $6.5M | ||
| Q3 24 | $-6.4M | $3.2M | ||
| Q2 24 | $-5.6M | $-2.2M | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
| Q4 25 | 14.7% | -51.1% | ||
| Q3 25 | 2.0% | 11.9% | ||
| Q2 25 | -26.4% | 7.5% | ||
| Q1 25 | -12.4% | -41.0% | ||
| Q4 24 | -8.9% | 39.6% | ||
| Q3 24 | -37.7% | 22.2% | ||
| Q2 24 | -28.8% | -18.0% | ||
| Q1 24 | -8.9% | — |
| Q4 25 | 26.3% | -60.3% | ||
| Q3 25 | 78.6% | 13.2% | ||
| Q2 25 | -32.0% | 1.0% | ||
| Q1 25 | -28.9% | -35.8% | ||
| Q4 24 | -26.4% | 35.6% | ||
| Q3 24 | -51.6% | 18.0% | ||
| Q2 24 | -42.6% | -16.4% | ||
| Q1 24 | -20.4% | — |
| Q4 25 | $0.26 | $-0.06 | ||
| Q3 25 | $0.75 | $0.03 | ||
| Q2 25 | $-0.27 | $0.00 | ||
| Q1 25 | $-0.40 | $-0.05 | ||
| Q4 24 | $-0.30 | $0.10 | ||
| Q3 24 | $-0.60 | $0.03 | ||
| Q2 24 | $-0.56 | $-0.03 | ||
| Q1 24 | $-0.42 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.6M | $14.7M |
| 总债务越低越好 | $43.1M | — |
| 股东权益账面价值 | $-46.3M | $48.2M |
| 总资产 | $53.6M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $19.6M | $14.7M | ||
| Q3 25 | $7.6M | $13.6M | ||
| Q2 25 | $3.4M | $17.9M | ||
| Q1 25 | $4.9M | $19.5M | ||
| Q4 24 | $8.6M | $19.8M | ||
| Q3 24 | $7.6M | $27.4M | ||
| Q2 24 | $10.3M | $23.4M | ||
| Q1 24 | $14.3M | — |
| Q4 25 | $43.1M | — | ||
| Q3 25 | $45.8M | — | ||
| Q2 25 | $63.3M | — | ||
| Q1 25 | $67.2M | — | ||
| Q4 24 | $68.1M | — | ||
| Q3 24 | $69.5M | — | ||
| Q2 24 | $69.2M | — | ||
| Q1 24 | $69.0M | — |
| Q4 25 | $-46.3M | $48.2M | ||
| Q3 25 | $-49.4M | $52.9M | ||
| Q2 25 | $-61.2M | $49.9M | ||
| Q1 25 | $-58.2M | $45.2M | ||
| Q4 24 | $-55.8M | $43.2M | ||
| Q3 24 | $-58.0M | $32.4M | ||
| Q2 24 | $-52.1M | $28.6M | ||
| Q1 24 | $-46.8M | — |
| Q4 25 | $53.6M | $82.3M | ||
| Q3 25 | $50.6M | $82.3M | ||
| Q2 25 | $52.8M | $78.5M | ||
| Q1 25 | $56.7M | $73.9M | ||
| Q4 24 | $64.9M | $73.4M | ||
| Q3 24 | $59.9M | $61.6M | ||
| Q2 24 | $62.9M | $91.5M | ||
| Q1 24 | $74.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.0M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | -4.98× | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
| Q4 25 | $-15.0M | $2.0M | ||
| Q3 25 | $120.0K | $-3.7M | ||
| Q2 25 | $-4.8M | $-5.2M | ||
| Q1 25 | $-5.7M | $-5.1M | ||
| Q4 24 | $-12.0M | $4.0M | ||
| Q3 24 | $-1.9M | $4.1M | ||
| Q2 24 | $-1.4M | $-3.6M | ||
| Q1 24 | $-5.1M | — |
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | — | — |
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | — |
| Q4 25 | -4.98× | — | ||
| Q3 25 | 0.01× | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GREE
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
